News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Conference News AHA 2017 Getting It On? Carry On: Sudden Cardiac Arrest Risk Low With Sexual Activity Yael L. Maxwell November 12, 2017
News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Conference News AHA 2016 Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women L.A. McKeown November 17, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Conference News AHA 2016 No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION Shelley Wood November 13, 2016
News Conference News AHA 2015 Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact Todd Neale November 12, 2015
News Conference News AHA 2015 Female Cardiologists Underpaid and Outnumbered, with Ramifications for Patients and Profession Shelley Wood November 09, 2015
News Conference News AHA 2014 Role of CTA in Survival Prediction, Resource Utilization Explored November 17, 2014
News Conference News AHA 2014 Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year Yael L. Maxwell November 17, 2014
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014
News Conference News AHA 2013 Registry Study Summarizes Initial US Experience with First Approved TAVR Device Jason Kahn November 16, 2013